Tandem Diabetes Care (Nasdaq:TNDM) announced today that it received clearance for the use of rapid-acting insulin with its ...

Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...

DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...

A parenting expert has given five top tips to help parents adjust to a quieter household as millions of students prepare to ...

Earlier this year, Abbott integrated its FreeStyle Libre 2 Plus sensor with Tandem’s t:slim X2 insulin pump and Insulet received a CE mark for the integration of its Omnipod 5 pump with the company’s ...

Some better-ranked stocks in the broader medical space are TransMedix Group TMDX, Veracyte VCYT and Boston Scientific BSX. While TransMedix Group and Veracyte currently sport a Zacks Rank #1 (Strong ...

Abbott’s FreeStyle Libre devices involve a small sensor applied to the skin ... more than six million users who have type 1 or type 2 diabetes. She added that the collaboration provides people ...

ABT made its CGM system Lingo available in the United States. The system can be used by consumers aged 18 years and older who ...

The planned launch of Omnipod 5 with Abbott's Freestyle Libre 2 Plus sensor is likely to drive further growth in the U.S. markets.

Foreign exchange fluctuation is a major headwind for ABT, as a considerable percentage of its revenues comes from outside the ...

Both of Abbott's over-the-counter CGMS are based on its popular FreeStyle Libre sensor technology ... It was designed for people with Type 2 diabetes and prediabetes in mind, so they can see ...